US Stocks

Checkpoint Therapeutics, Inc.

Checkpoint Therapeutics is an oncology company that focuses on the acquisition, development, and commercialization of treatments for solid tumor cancers. Its lead product candidates include Cosibelimab, CK-302, and Olafertinib. The company is also collaborating with TG Therapeutics to develop and commercialize certain assets in the field of hematological malignancies.